OR WAIT null SECS
February 05, 2021
Two-dose COVAXIN currently under EUA in India
Rating for packaging supplier highlights its commitment to sustainable practices and corporate social responsibility
February 02, 2021
In Phase III at the moment, mRNA dose will be produced at Bayer's Wuppertal, Germany facility
January 30, 2021
Production expected to begin in the second quarter
January 23, 2021
Boston-area location will be fully operational in Q4
January 22, 2021
Latest air cargo collaboration provides pandemic response support
January 12, 2021
Unnamed US facility will increase company's manufacturing capacity
January 11, 2021
These organizations are encouraged to consider all alternatives when planning their packaging, serialization and validation strategies
January 04, 2021
Liquid pharmaceuticals can serve as needed alternatives in hospitals and other care settings
December 22, 2020
Acquisition grows company's chemical manufacturing and R&D network